Astrana Health, Inc.
$31.45
▲
2.2%
2026-04-21 05:26:01
www.astranahealth.com
NCM: ASTH
Explore Astrana Health, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.56 B
Current Price
$31.45
52W High / Low
$34.8 / $18.08
Stock P/E
69.19
Book Value
$15.94
Dividend Yield
0.51%
ROCE
4.9%
ROE
4.49%
Face Value
—
EPS
$0.46
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
3,000
Beta
0.77
Debt / Equity
193.1
Current Ratio
1.4
Quick Ratio
1.4
Forward P/E
9.24
Price / Sales
0.48
Enterprise Value
$1.79 B
EV / EBITDA
12.47
EV / Revenue
0.56
Rating
None
Target Price
$36
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Basel Medical Group Ltd | $0.62 | — | $10.73 M | — | -25.54% | -1.64% | $9.4 / $0.49 | $0.23 |
| 2. | LifeStance Health Group, Inc. | $6.92 | 277.93 | $2.69 B | — | 1.24% | 0.65% | $8.09 / $3.74 | $3.92 |
| 3. | Tenet Healthcare Corporation | $189.93 | 12.26 | $16.56 B | — | 13.64% | 27.02% | $247.21 / $109.82 | $48.53 |
| 4. | National HealthCare Corporation | $166.58 | 21.66 | $2.6 B | 1.54% | 10.08% | 11.92% | $177.47 / $89.4 | $68.79 |
| 5. | Universal Health Services, Inc. | $180.51 | 7.82 | $11.04 B | 0.45% | 16.23% | 21.33% | $246.32 / $152.33 | $119.15 |
| 6. | COMPASS Pathways plc | $9.46 | — | $639.93 M | — | 468.11% | -5.65% | $8.9 / $2.25 | $-0.55 |
| 7. | Acadia Healthcare Company, Inc. | $27.84 | — | $2.56 B | — | 7.76% | -40.96% | $28.48 / $11.43 | $21.55 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 950.53 M | 956.05 M | 654.81 M | 620.39 M | 665.21 M |
| Operating Profit | 18.39 M | 19.21 M | 20.34 M | 20.58 M | 0.72 M |
| Net Profit | 6 M | 0.37 M | 9.42 M | 6.69 M | -6.95 M |
| EPS in Rs | 0.11 | 0.01 | 0.17 | 0.12 | -0.13 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 3.18 B | 2.03 B | 1.39 B | 1.14 B |
| Operating Profit | 78.53 M | 89.35 M | 84.61 M | 104.27 M |
| Net Profit | 22.49 M | 43.15 M | 60.72 M | 45.17 M |
| EPS in Rs | 0.4 | 0.78 | 1.09 | 0.81 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 2.22 B | 1.35 B | 933.36 M | 966.21 M |
| Total Liabilities | 1.66 B | 840.73 M | 522.59 M | 407.67 M |
| Equity | 779.29 M | 712.72 M | 614.22 M | 542.56 M |
| Current Assets | 863.31 M | 638.5 M | 461.51 M | 428.12 M |
| Current Liabilities | 615.27 M | 365.61 M | 218.67 M | 148.61 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 114.6 M | 52.2 M | 68.23 M | 82.13 M |
| Investing CF | -539 M | -192.4 M | -65.52 M | -7.11 M |
| Financing CF | 569.35 M | 135.15 M | 3.42 M | -20.09 M |
| Free CF | 104.49 M | 44.17 M | 39.7 M | 59.19 M |
| Capex | -10.11 M | -8.03 M | -28.53 M | -22.94 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 46.72% | 21.19% | — | — |
| Earnings Growth % | -28.93% | 34.42% | — | — |
| Profit Margin % | 2.12% | 4.38% | 3.95% | — |
| Operating Margin % | 4.39% | 6.1% | 9.11% | — |
| Gross Margin % | 13.34% | 15.5% | 17.43% | — |
| EBITDA Margin % | 6.97% | 8.92% | 9.8% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.